Original reportCommon Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity With Depression-Anxiety Disorders
Key words
Cited by (0)
Supported by the United States National Institute of Mental Health, Bethesda, MD (R01MH070884), the John D. and Catherine T. MacArthur Foundation, Chicago, IL, the Pfizer Foundation, New York, NY, the U.S. Public Health Service, Washington, DC (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center, Bethesda, MD (FIRCA R01-TW006481), the Pan American Health Organization, Washington, DC, Eli Lilly and Company, Indianapolis, IN, Ortho-McNeil Pharmaceutical, Inc, Titusville, NJ, Glaxo SmithKline, Middlesex, UK, and Bristol-Myers Squibb, Philadelphia, PA. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation, New York, NY. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection, Bogotá D.C., Colombia. The ESEMeD project is funded by the European Commission, Bruxelles, Belgium (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Madrid, Spain, Instituto de Salud Carlos III, Madrid, Spain (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from Glaxo SmithKline, Middlesex, UK. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel, Tel Hashomer, Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare, Tokyo, Japan. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Berchem, Belgium, Eli Lilly and Company, Indianapolis, IN, Glaxo SmithKline, Middlesex, UK, Roche, Basel, Switzerland, and Novartis, Basel, Switzerland. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente, Mexico City, Mexico (INPRFMDIES 4280) and by the National Council on Science and Technology, Benito Juárez C.P., Mexico (CONACyT-G30544-H), with supplemental support from the Pan American Health Organization (PAHO), Washington, DC, Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council, Wellington, New Zealand. The Nigerian Survey of Mental Health and Well-Being (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The South Africa Stress and Health Study (SASH) is supported by the U.S. National Institute of Mental Health, Bethesda, MD (R01-MH059575) and National Institute of Drug Abuse, Bethesda, MD with supplemental funding from the South African Department of Health, Pretoria, South Africa, and the University of Michigan, Ann Arbor, MI. The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study is funded by the U.S. National Institute of Mental Health, Bethesda, MD (RO1-MH61905). The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health, Bethesda, MD (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), Bethesda, MD, the Substance Abuse and Mental Health Services Administration, Rockville, MD (SAMHSA), the Robert Wood Johnson Foundation, Princeton, NJ (RWJF; Grant 044708), and the John W. Alden Trust, Boston, MA.